CCN1 and laryngotracheoesophageal cleft: CYR61 concentrations in plasma were elevated in all LC patients (13.7 ± 18.6 ng·mL−1) compared with all healthy controls (0.29 ± 0.22 ng·mL−1; P = 0.0003).